Clinical trial

p16 Methylation for Smoking Cessation

NCT01038492

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-04-01

PhaseNA

Study timeline

Study start (unknown)2009-04-01Date precision: month

Registry last updated2013-06-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tobacco Use Disorderunresolved

Smoking Cessationunresolved

Lung Cancerunresolved

Interventions

p16 Methylation and Lung Cancer EducationBEHAVIORAL

Sponsors & collaborators

Duke Universitylead sponsor

Durham VA Medical Centercollaborator

Cancer and Leukemia Group Bcollaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01038492 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.